Literature DB >> 14609789

Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Jennifer R Mertens1, Yun W Lu, Sujaya Parthasarathy, Charles Moore, Constance M Weisner.   

Abstract

BACKGROUND: Substance abuse and health problems seem to be inextricably related. Yet, prior research on the health conditions related to substance abuse is largely focused on alcohol and is from patients treated in publicly funded programs, inpatients, and the general population.
METHODS: This study compares the prevalence of medical and psychiatric conditions among 747 substance abuse patients and 3690 demographically matched controls from the same health maintenance organization, and examines whether any heightened prevalence for substance abuse patients (relative to controls) varies according to demographic subgroups and type of substance.
RESULTS: Approximately one third of the conditions examined were more common among substance abuse patients than among matched controls, and many of these conditions were among the most costly. We also found that pain-related diagnoses, including arthritis, headache, and lower back pain, were more prevalent among such patients, particularly those dependent on narcotic analgesics.
CONCLUSIONS: Our findings point to the importance of examining comorbid medical conditions and substance abuse in both primary and specialty care. Our findings regarding pain-related diagnoses among patients dependent on narcotic analgesics highlight the need for linkages between primary care and substance abuse treatment. Moreover, optimal treatment of many common medical disorders may require identification, intervention, and treatment of an underlying substance abuse disorder.

Entities:  

Mesh:

Year:  2003        PMID: 14609789     DOI: 10.1001/archinte.163.20.2511

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  101 in total

1.  Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system.

Authors:  Timothy C Durazzo; Anderson Mon; Stefan Gazdzinski; Dieter J Meyerhoff
Journal:  Addict Biol       Date:  2011-11-09       Impact factor: 4.280

2.  Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders.

Authors:  Shannon Byrne; Nancy M Petry
Journal:  AIDS Care       Date:  2012-05-30

3.  Probability and predictors of treatment-seeking for substance use disorders in the U.S.

Authors:  Carlos Blanco; Miren Iza; Jorge Mario Rodríguez-Fernández; Enrique Baca-García; Shuai Wang; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2015-02-09       Impact factor: 4.492

Review 4.  Secondary headaches.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2006-10

5.  Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.

Authors:  Udi E Ghitza; Betty Tai
Journal:  J Health Care Poor Underserved       Date:  2014-02

6.  12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity.

Authors:  Felicia W Chi; Stacy Sterling; Cynthia I Campbell; Constance Weisner
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

7.  Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts: a population-based approach.

Authors:  Judith Bernstein; Taletha M Derrington; Candice Belanoff; Howard J Cabral; Hermik Babakhanlou-Chase; Hafsatou Diop; Stephen R Evans; Hilary Jacobs; Milton Kotelchuck
Journal:  Drug Alcohol Depend       Date:  2014-12-04       Impact factor: 4.492

8.  The association of injury with substance use disorder among women of reproductive age: an opportunity to address a major contributor to recurrent preventable emergency department visits?

Authors:  Judith Bernstein; Edward Bernstein; Candice Belanoff; Howard J Cabral; Hermik Babakhanlou-Chase; Taletha M Derrington; Hafsatou Diop; Carole Douriez; Stephen R Evans; Hilary Jacobs; Milton Kotelchuck
Journal:  Acad Emerg Med       Date:  2014-12       Impact factor: 3.451

9.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

10.  Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Authors:  Derek D Satre; Gerald N DeLorenze; Charles P Quesenberry; Ailin Tsai; Constance Weisner
Journal:  Psychiatr Serv       Date:  2013-08-01       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.